Erratum to: Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients
Carlo Buonerba, Piera Federico, Carmine D’Aniello, Pasquale Rescigno, Carla Cavaliere, Livio Puglia, Matteo Ferro, Vincenzo Altieri, Sisto Perdonà, Sabino De Placido, Giuseppe Di LorenzoVolume:
67
Pages:
1
DOI:
10.1007/s00280-011-1626-8
Date:
June, 2011
File:
PDF, 86 KB
2011